-
1
-
-
84944656960
-
The Food and Drug Administration and medroxyprogesterone acetate: What are the issues?
-
Rosenfield A, Maine D, Rochat R, et al. The Food and Drug Administration and medroxyprogesterone acetate: what are the issues? JAMA 1983; 249: 2922-8
-
(1983)
JAMA
, vol.249
, pp. 2922-2928
-
-
Rosenfield, A.1
Maine, D.2
Rochat, R.3
-
2
-
-
0027762576
-
Depot-medroxyprogesterone acetate (DMPA) and cancer: Memorandum from a WHO meeting 1993
-
World Health Organization. Depot-medroxyprogesterone acetate (DMPA) and cancer: memorandum from a WHO meeting 1993; Bull World Health Organ 1993; 71 (6): 669-76
-
(1993)
Bull World Health Organ
, vol.71
, Issue.6
, pp. 669-676
-
-
-
3
-
-
0028235278
-
Depot-medroxyprogesterone acetate, other injectable contraceptives, and cervical neoplasia
-
Mar
-
La Vecchia C. Depot-medroxyprogesterone acetate, other injectable contraceptives, and cervical neoplasia. Contraception 1994 Mar; 49: 223-30
-
(1994)
Contraception
, vol.49
, pp. 223-230
-
-
La Vecchia, C.1
-
4
-
-
0028200315
-
Breast cancer and depot-medroxyprogesterone acetate: A review
-
Mar
-
Chilvers C. Breast cancer and depot-medroxyprogesterone acetate: a review. Contraception 1994 Mar; 49: 211-22
-
(1994)
Contraception
, vol.49
, pp. 211-222
-
-
Chilvers, C.1
-
5
-
-
0027950025
-
Depot-medroxyprogesterone acetate (DMPA) and cancer of the endometrium and ovary
-
Mar
-
Lumbiganon P. Depot-medroxyprogesterone acetate (DMPA) and cancer of the endometrium and ovary. Contraception 1994 Mar; 49: 203-9
-
(1994)
Contraception
, vol.49
, pp. 203-209
-
-
Lumbiganon, P.1
-
6
-
-
0028946370
-
Depot medroxyprogesterone acetate and breast cancer: A pooled analysis of the WHO and New Zealand studies
-
Mar 8
-
Skegg DCG, Noonan EA, Paul C, et al. Depot medroxyprogesterone acetate and breast cancer: a pooled analysis of the WHO and New Zealand studies. JAMA 1995 Mar 8; 273 (10): 799-804
-
(1995)
JAMA
, vol.273
, Issue.10
, pp. 799-804
-
-
Skegg, D.C.G.1
Noonan, E.A.2
Paul, C.3
-
7
-
-
0025781746
-
Breast cancer and depot-medroxyprogesterone acetate: A multinational study
-
WHO Collaborative Study of Neoplasia and Steroid Contraceptives. Breast cancer and depot-medroxyprogesterone acetate: a multinational study. Lancet 1991; 338: 833-8
-
(1991)
Lancet
, vol.338
, pp. 833-838
-
-
-
8
-
-
0024441743
-
Depot medroxyprogesterone (Depo-Provera) and risk of breast cancer
-
Paul C, Skegg DCG, Spears GFS. Depot medroxyprogesterone (Depo-Provera) and risk of breast cancer. BMJ 1989; 299: 759-62
-
(1989)
BMJ
, vol.299
, pp. 759-762
-
-
Paul, C.1
Skegg, D.C.G.2
Spears, G.F.S.3
-
9
-
-
0023581880
-
A case-control study of breast cancer and hormonal contraception in Costa Rica
-
Lee NC, Rosera-Bixby L, Oberle MW, et al. A case-control study of breast cancer and hormonal contraception in Costa Rica. J Natl Cancer Inst 1987; 79: 1247-54
-
(1987)
J Natl Cancer Inst
, vol.79
, pp. 1247-1254
-
-
Lee, N.C.1
Rosera-Bixby, L.2
Oberle, M.W.3
-
10
-
-
84944660622
-
Risk of breast, uterine corpus and ovarian cancer in women receiving medroxyprogesterone injections
-
Liang AP, Greenspan Levenson A, Layde PM, et al. Risk of breast, uterine corpus and ovarian cancer in women receiving medroxyprogesterone injections. JAMA 1983; 249: 2909-12
-
(1983)
JAMA
, vol.249
, pp. 2909-2912
-
-
Liang, A.P.1
Greenspan Levenson, A.2
Layde, P.M.3
-
11
-
-
0018958905
-
The association of depo-medroxyprogesterone acetate and breast cancer
-
Greenspan AR, Hatcher RA, Moore M, et al. The association of depo-medroxyprogesterone acetate and breast cancer. Contraception 1980; 21: 563-9
-
(1980)
Contraception
, vol.21
, pp. 563-569
-
-
Greenspan, A.R.1
Hatcher, R.A.2
Moore, M.3
-
13
-
-
0023938931
-
Subgroup analysis
-
Bulpitt CJ. Subgroup analysis. Lancet 1988; II: 31-44
-
(1988)
Lancet
, vol.2
, pp. 31-44
-
-
Bulpitt, C.J.1
-
14
-
-
0002255973
-
Statistical aspects of cancer trials
-
Peto R. Statistical aspects of cancer trials. Treatment of cancer. 1982; 44: 867-71
-
(1982)
Treatment of Cancer
, vol.44
, pp. 867-871
-
-
Peto, R.1
-
15
-
-
0023831045
-
Potential for bias in case-control studies of oral contraceptives and breast cancer
-
Skegg DCG. Potential for bias in case-control studies of oral contraceptives and breast cancer. Am J Epidemiol 1988; 127: 205-12
-
(1988)
Am J Epidemiol
, vol.127
, pp. 205-212
-
-
Skegg, D.C.G.1
-
16
-
-
0023715395
-
Short-term increase in breast cancer risk following a full-term pregnancy
-
Bruzzi P, Negri E, La Vecchia C, et al. Short-term increase in breast cancer risk following a full-term pregnancy. BMJ 1988: 297: 1096-8
-
(1988)
BMJ
, vol.297
, pp. 1096-1098
-
-
Bruzzi, P.1
Negri, E.2
La Vecchia, C.3
-
17
-
-
0028228254
-
Transient increase in the risk of breast cancer after giving birth
-
Lambe M, Hsieh C, Trichopoulos D, et al. Transient increase in the risk of breast cancer after giving birth. N Engl J Med 1994; 331: 5-9
-
(1994)
N Engl J Med
, vol.331
, pp. 5-9
-
-
Lambe, M.1
Hsieh, C.2
Trichopoulos, D.3
-
18
-
-
0024836171
-
Oral contraceptive use influences resting breast proliferation
-
Anderson TJ, Battersby S, King RJB, et al. Oral contraceptive use influences resting breast proliferation. Hum Pathol 1989; 20: 1139-44
-
(1989)
Hum Pathol
, vol.20
, pp. 1139-1144
-
-
Anderson, T.J.1
Battersby, S.2
King, R.J.B.3
-
19
-
-
0023793193
-
The effect of age and menstrual cycle upon proliferative activity of the normal human breast
-
Potten CS, Watson RJ, Williams GT, et al. The effect of age and menstrual cycle upon proliferative activity of the normal human breast Br J Cancer 1988; 58: 163-70
-
(1988)
Br J Cancer
, vol.58
, pp. 163-170
-
-
Potten, C.S.1
Watson, R.J.2
Williams, G.T.3
-
20
-
-
0027375476
-
Estrogen and progestin effects in human breast carcinogenesis
-
King RJB, Estrogen and progestin effects in human breast carcinogenesis. Breast Cancer Res Treat 1993; 27: 3-15
-
(1993)
Breast Cancer Res Treat
, vol.27
, pp. 3-15
-
-
King, R.J.B.1
|